Benefits of Elective Para-Aortic Radiotherapy for pN1 Prostate Cancer Using Arc Therapy (Intensity-Modulated or Volumetric Modulated Arc Therapy): Protocol for a Nonrandomized Phase II Trial

Cédric Draulans   ¹ , MD ;   Steven Joniau   ² , MD, PhD ;   Valérie Fonteyne   ³ , MD, PhD ;   Louke Delrue   ⁴ , MD, PhD ;   Karel Decaestecker   ⁵ , MD, PhD ;   Wouter Everaerts   ² , MD, PhD ;   Piet Dirix   ⁶ , MD, PhD ;   Laura Van den Bergh   ⁷ , MD, PhD ;   Wouter Crijns   ¹ , PhD ;   Hans Vandendriessche   ⁸ , MD ;   Lodewijk Van Wynsberge   ⁹ , MD ;   Piet Ost   ³ , MD, PhD ;   Nicolaas Lumen   ⁵ , MD, PhD ;   Pieterjan Buelens   ¹ , MD ;   Karin Haustermans   ¹ , MD, PhD ;   Charlien Berghen   ¹ , MD ;   Gert De Meerleer   ¹ , MD, PhD

¹ Department of Radiation Oncology, University Hospitals Leuven, University of Leuven, Leuven, Belgium

² Department of Urology, University Hospitals Leuven, University of Leuven, Leuven, Belgium

³ Department of Radiation Oncology, Ghent University Hospital, University of Ghent, Ghent, Belgium

⁴ Department of Radiology, Ghent University Hospital, University of Ghent, Ghent, Belgium

⁵ Department of Urology, Ghent University Hospital, University of Ghent, Ghent, Belgium

⁶ Department of Radiation Oncology, Iridium Cancer Network, Wilrijk, Antwerp, Belgium

⁷ Department of Radiation Oncology, Limburg Oncology Centre, Hasselt, Belgium

⁸ Department of Urology, AZ Jan Portaels, Vilvoorde, Belgium

⁹ Department of Urology, General Regional Hospital Tienen, Tienen, Belgium